Judit Kocsis

2PUBLICATIONS
8CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 03, 2020
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma.

Nizar M Tannir, Sabina Signoretti, Toni K Choueiri

|Jun 29, 2018
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with <i>RAS</i>-Mutated Hepatocellular Carcinoma.

Ho Yeong Lim, Philippe Merle, Karl Heinz Weiss

Pageof 1